InvestorsHub Logo

nidan7500

02/07/23 4:51 PM

#402009 RE: Twice Worthy #401999

Twice Worthy

especially, with our desperate FDA approving a new Alzheimers drug causing that causes brains to bleed and patients to die.



Exactly correct, that what I also believe is different this time around. For the first time in over 100 years the FDA leadership and CNS patients will begin to see AD (other CNS) treatments based on a process-treatment which will actually not put them at risk and which will begin the recovery process for most of them. I have often wondered just HOW the top FDA (NIH-all the rest) of the established BioPharm (BP) will react when the GREAT AWAKENING starts???. We'll know it when we see it of course, but that is some of the hill we must climb.

It is becoming more clear every day. We have a front row seat. When WS sees this, all hell will break lose.

crescentmotor

02/07/23 11:56 PM

#402062 RE: Twice Worthy #401999

Very interesting that during the CC that foreign countries drug regulators could be focusing on Anavex and possible approval of Anavex drugs and, Anavec very aware of this ... and the possibility that our FDA would need to play catch-up



Given the questionable interactions/connections between BP and the U.S. regulatory health agencies, Missling made a very smart move (over and above minimizing trial expenses) to conduct many of the Anavex trials overseas.